Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|June 13, 2009
Endurance capacity, not body size, determines physical activity levels: role of skeletal muscle PEPCKColleen M Novak, Carlos Escande, Susan M Gerber, et al.
Endocrinology|July 19, 2008
Osteitis fibrosa is mediated by Platelet-Derived Growth Factor-A via a phosphoinositide 3-kinase-dependent signaling pathway in a rat model for chronic hyperparathyroidismMalcolm B Lowry, Sutada Lotinun, Alexey A Leontovich, et al.
Nature Communications|October 13, 2019
ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancerArun Kanakkanthara, Catherine J Huntoon, Xiaonan Hou, et al.
Hormones and Behavior|March 31, 2010
Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacityColleen M Novak, Carlos Escande, Paul R Burghardt, et al.
Frontiers in Immunology|May 25, 2026
Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as encephalitis and concurrent Epstein-Barr virus detection: a case seriesRunzhe Chen, Xianli Song, Yupeng Du, et al.
Bone|January 25, 2011
Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblastsMeghan E McGee-Lawrence, Angela L McCleary-Wheeler, Frank J Secreto, et al.
Frontiers in Oncology|June 14, 2024
Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancerAndrew Takchi, Minzhi Zhang, Mohammad Jalalirad, et al.
Signal Transduction and Targeted Therapy|December 11, 2025
Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trialTao Liu, Jiao Wang, Zhihao Zhao, et al.
Oncogene|March 6, 2021
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistanceMohammad Jalalirad, Tufia C Haddad, Jeffrey L Salisbury, et al.
Journal of Cellular Biochemistry|March 22, 2005
Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarrayJude E Onyia, Leah M Helvering, Lawrence Gelbert, et al.
Pageof 2